nimbolide has been researched along with Lymphoma, T-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaiswara, PK; Kumar, A | 1 |
| Gupta, VK; Jaiswara, PK; Kumar, A; Kumar, S; Pathak, C; Rawat, SG; Sonker, P; Tiwari, RK | 1 |
2 other study(ies) available for nimbolide and Lymphoma, T-Cell
| Article | Year |
|---|---|
Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Glucose; Homeostasis; Hydrogen-Ion Concentration; Limonins; Lymphoma, T-Cell; Male; Mice; Reactive Oxygen Species | 2022 |
Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glucose; Humans; Limonins; Lymphoma, T-Cell; Reactive Oxygen Species | 2021 |